研究業績

2025年

  1. Shoji K, Asai Y, Tsuzuki S, Matsunaga N, Suzuki S, Iwamoto N, Funaki T, Miyairi I, Ohmagari N. Comparison of clinical characteristics and severity of COVID-19 with or without viral co-infection in hospitalized children. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2025;31(2):102520.
  2. Myojin S, Shoji K, Saito J, Tao C, Kato H, Uchida H, Fukuda A, Sakamoto S, Kasahara M, Miyairi I. Daptomycin treatment for persistent bacteremia in a pediatric solid organ transplant recipient: Case report and literature review. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2025;31(1):102506.
  3. Morioka S, Tsuzuki S, Gu Y, Fujitomo Y, Soeda H, Nakahama C, Hasegawa N, Maesaki S, Maeda M, Matsumoto T, Miyairi I, Ohmagari N. Factors associated with the change of antimicrobial prescription before and after the national action plan on antimicrobial resistance: Additional analysis of a nationwide survey conducted by the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2025;31(2):102532.
  4. Mori M, Ito Y, Ishiwada N, Ito K, Shinjoh M, Tsugawa T, Funaki T, Furuichi M, Hoshino T, Miyairi I, Kondo T, Hinoki A, Wada M, Okada K, Korematsu S, Tanuma N, Hasegawa H, Hosoi K, Yoshizaki K, Ishige M. Risks and prevention of severe respiratory syncytial virus infection among infants and children with pulmonary hypoplasia, airway stenosis, congenital esophageal atresia, inborn errors of metabolism, or neuromuscular diseases in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2025;31(3):102588.
  5. Miyairi I, Miyazawa S, Takahashi Y, Kojima S, Kitanishi Y, Ogura E. Incidence of severe illness in pediatric influenza outpatients treated with baloxavir or neuraminidase inhibitors. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2025;31(3):102606.
  6. Kasai T, Yamada M, Funaki T, Tao C, Myojin S, Aiba H, Matsui T, Ogimi C, Miyake K, Ueno S, Miyairi I, Kato H, Shoji K. Antibody titer trends after SARS-CoV-2 vaccination in patients aged 12-25 years with underlying diseases. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2025;31(3):102579.
  7. Ito Y, Yamagishi T, Ikenoue C, Ishiwada N, Ito K, Iwatani S, Ouchi K, Kawana K, Shimizu H, Shinjoh M, Takeuchi N, Tsugawa T, Funaki T, Furuichi M, Hoshino T, Mikamo H, Miyairi I, Moriuchi H, Morioka I, Yamagishi Y, Mori M. Clinical Practice Guidelines for the Management of Congenital Syphilis in Japan, 2023: Executive Summary. The Pediatric infectious disease journal. 2025;44(3):e90-e4.
  8. Hikino K, Shoji K, Saito J, Fukunaga K, Liu X, Matsui T, Utano T, Takebayashi A, Tomizawa D, Kato M, Matsumoto K, Ishikawa T, Kawai T, Nakamura H, Miyairi I, Terao C, Mushiroda T. Analysis of factors influencing the relationship between voriconazole plasma concentrations and adverse effects in a paediatric population. British journal of clinical pharmacology. 2025.

2024年

  1. Yasuda M, Shoji K, Tomita K, Uchida Y, Uematsu S, Yoshida K, Kono N, Funatsu M, Miyairi I. Clinical and Laboratory Diagnosis of Exanthems Among Japanese Children Younger Than 6 Years Old in the Post-Measles-Rubella Vaccine Era. The Pediatric infectious disease journal. 2024;43(2):e44-e8.
  2. Shoji K, Uchida Y, Uematsu S, Ikuse T, Miyairi I. Case Series of Vaccine Hesitancy Encountered at the Pediatric Emergency Department. Cureus. 2024;16(11):e74777.
  3. Shoji K, Nishiya K, Miyairi I, Saitoh A, Uematsu S, Ishiguro A, Engle JM, Saint S. Effective mentoring in pediatrics. Pediatrics international : official journal of the Japan Pediatric Society. 2024;66(1):e15731.
  4. Shoji K, Hikino K, Saito J, Matsui T, Utano T, Takebayashi A, Tomizawa D, Kato M, Matsumoto K, Ishikawa T, Kawai T, Nakamura H, Miyairi I, Terao C, Mushiroda T. Pharmacogenetic implementation for CYP2C19 and pharmacokinetics of voriconazole in children with malignancy or inborn errors of immunity. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024;30(12):1280-8.
  5. Saitoh A, Nishiya K, Miyairi I, Shoji K, Ishiwada N, Katayose M, Hoshino T, Ohga S, Moriuchi H, Ouchi K. Launch of Board Certification in Pediatric Infectious Diseases in Japan. The Pediatric infectious disease journal. 2024;43(8):e270-e4.
  6. Otake S, Shoji T, Yamada K, Kimura M, Myojin S, Kamiyoshi N, Ochi F, Nezu M, Ishida A, Miyairi I, Kasai M. Trend in antibiotic prescription at pediatric primary emergency medical centers in Japan: A multi-center, cross-sectional study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024;30(7):616-20.
  7. Okubo Y, Uda K, Miyairi I. Clinical Practice Patterns, Health Resource Use and Risk Factors for Severe Conditions Among Children Hospitalized With COVID-19 in Japan. The Pediatric infectious disease journal. 2024;43(1):26-31.
  8. Okubo Y, Uda K, Miyairi I. Long-term Effectiveness of Financial Incentives for Not Prescribing Unnecessary Antibiotics to Children with Acute Respiratory and Gastrointestinal Infections: A Japan's Nationwide Quasi-Experimental Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024.
  9. Okubo Y, Uda K, Kaki M, Miyoshi S, Miyairi I. Infection prevention measures and its determinants in childcare facilities during the COVID-19 pandemic: A nationwide survey (2022-2023). Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024;30(5):379-86.
  10. Okubo Y, Nakabayashi Y, Ito K, Uda K, Miyairi I. Nationwide epidemiology and health resource use among children with COVID-19 in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024;30(10):1041-6.
  11. Mizushima H, Uchida H, Kitagata R, Isobe Y, Toyama C, Nara K, Miyairi I. Rapid polymerase chain reaction-based diagnosis of yersiniosis causing recurrent intussusception. Pediatrics international : official journal of the Japan Pediatric Society. 2024;66(1):e15757.
  12. Miyabe Y, Fukuchi M, Tomizawa H, Nakamura Y, Jikei M, Matsuwaki Y, Arima M, Konno Y, Moritoki Y, Takeda M, Tanabe N, Shima H, Shiraishi Y, Hirai T, Ohta N, Takahata J, Matsubara A, Yamada T, Asano K, Miyairi I, Melo RCN, Weller PF, Ueki S. Aggregated eosinophils and neutrophils characterize the properties of mucus in chronic rhinosinusitis. The Journal of allergy and clinical immunology. 2024;153(5):1306-18.
  13. Matsubara D, Matsubara Y, Ayusawa M, Hamada H, Seki M, Yamagishi H, Mitani Y, Onouchi Y, Moriuchi H, Miyairi I, Tanaka-Taya K, Katsuta T, Kurosawa H, Aoki K, Shimizu N, Nakamura Y. Nationwide Survey of Multisystem Inflammatory Syndrome in Children Associated with Coronavirus Disease 2019 in Japan. Journal of clinical immunology. 2024;45(1):51.
  14. Ishikawa T, Uejima Y, Okai M, Shiga K, Shoji K, Miyairi I, Kato M, Morooka S, Kubota M, Tagaya T, Tsuji S, Aoki S, Ide K, Niimi H, Uchiyama T, Onodera M, Kawai T. Melting temperature mapping method in children: Rapid identification of pathogenic microbes. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024;30(6):475-80.
  15. Funaki T, Yamada M, Miyake K, Ueno S, Myojin S, Aiba H, Matsui T, Ogimi C, Kato H, Miyairi I, Shoji K. Safety and antibody response of the BNT162b2 SARS-CoV-2 vaccine in children aged 5-11 years with underlying diseases: A prospective observational study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024;30(8):773-9.
  16. Fujii Y, Ishigaki H, Miyairi I, Niizeki N, Nagura O, Yamashita K, Maekawa M, Furuhashi K. Age dependent discrepancy between SARS-CoV-2 anti-nucleoprotein antibody and anti-RBD spike protein antibody in children reflects vaccine coverage. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024;30(7):646-50.
  17. Choe SA, Choe YJ, Miyairi I. Universal versus risk-based strategies for vaccinating children against COVID-19: Japan and Korea. BMJ paediatrics open. 2024;8(1).
  18. Arashiro T, Kramer R, Jin J, Kano M, Wang F, Miyairi I. Inpatient Burden of Respiratory Syncytial Virus Infection and Influenza in Children Younger Than 5 Years in Japan, 2011-2022: A Database Study. Influenza and other respiratory viruses. 2024;18(11):e70045.

2023年

  1. Yamada M, Shoji K, Miyairi I, Kasahara M, Saitoh A. Pediatric Infectious Diseases Related to Transplantation: Insights From Japan. The Pediatric infectious disease journal. 2023;42(1):e18-e25.
  2. Uda K, Okubo Y, Tsuge M, Tsukahara H, Miyairi I. Impacts of routine varicella vaccination program and COVID-19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan. Vaccine. 2023;41(34):4958-66.
  3. Shoji K, Tsuzuki S, Akiyama T, Matsunaga N, Asai Y, Suzuki S, Iwamoto N, Funaki T, Yamada M, Ozawa N, Yamaguchi K, Miyairi I, Ohmagari N. Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023;29(1):33-8.
  4. Shoji K, Funaki T, Yamada M, Mikami M, Miyake K, Ueno S, Tao C, Myojin S, Aiba H, Matsui T, Ogimi C, Kato H, Miyairi I. Safety of and antibody response to the BNT162b2 COVID-19 vaccine in adolescents and young adults with underlying disease. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023;29(1):61-6.
  5. Shoji K, Asai Y, Akiyama T, Tsuzuki S, Matsunaga N, Suzuki S, Iwamoto N, Funaki T, Miyairi I, Ohmagari N. Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023;29(9):930-3.
  6. Sakaida K, Iwashima S, Katsuki J, Sato K, Miyairi I. Multisystem inflammatory syndrome in children after BNT162b2 messenger RNA SARS-CoV-2 vaccination. Pediatrics international : official journal of the Japan Pediatric Society. 2023;65(1):e15441.
  7. Saito J, Shoji K, Miyairi I, Yamatani A. Drug Formulation for Pediatric Oral Antimicrobial Agents in Japan: Current Status, Prospects, and Challenges. The Pediatric infectious disease journal. 2023;42(8):e298-e303.
  8. Okubo Y, Uda K, Miyairi I, Michihata N, Kumazawa R, Matsui H, Fushimi K, Yasunaga H. Nationwide epidemiology and clinical practice patterns of pediatric urinary tract infections: application of multivariate time-series clustering. Pediatric nephrology (Berlin, Germany). 2023;38(12):4033-41.
  9. Okubo Y, Uda K, Miyairi I. Trends in Influenza and Related Health Resource Use During 2005-2021 Among Children in Japan. The Pediatric infectious disease journal. 2023;42(8):648-53.
  10. Okubo Y, Nishi A, Uda K, Miyairi I, Michihata N, Kumazawa R, Matsui H, Fushimi K, Yasunaga H. Financial incentives for infection prevention and antimicrobial stewardship to reduce antibiotic use: Japan's nationwide observational study. The Journal of hospital infection. 2023;131:89-98.
  11. Myojin S, Michihata N, Shoji K, Takanashi JI, Matsui H, Fushimi K, Miyairi I, Yasunaga H. Prognostic factors among patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome: A retrospective cohort study using a nationwide inpatient database in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023;29(6):610-4.
  12. Katsuta T, Aizawa Y, Shoji K, Shimizu N, Okada K, Nakano T, Kamiya H, Amo K, Ishiwada N, Iwata S, Oshiro M, Okabe N, Korematsu S, Suga S, Tsugawa T, Nishimura N, Hishiki H, Fujioka M, Hosoya M, Mizuno Y, Miyairi I, Miyazaki C, Morishima T, Yoshikawa T, Wada T, Ouchi K, Moriuchi H, Tanaka-Taya K, Saitoh A. Acute and Postacute Clinical Characteristics of Coronavirus Disease 2019 in Children in Japan. The Pediatric infectious disease journal. 2023;42(3):240-6.
  13. Kato H, Shoji K, Jinguji M, Nishimura N, Nakagawa S, Miyairi I. The Utility of Performing Anaerobic Blood Cultures in Pediatric Intensive Care Units. Journal of the Pediatric Infectious Diseases Society. 2023;12(6):372-8.
  14. Ishiwada N, Shinjoh M, Kusama Y, Arakawa H, Ohishi T, Saitoh A, Suzuki A, Tsutsumi H, Nishi J, Hoshino T, Mitsuda T, Miyairi I, Iwamoto-Kinoshita N, Kobayashi H, Satoh K, Shimizu A, Takeshita K, Tanaka T, Tamura D, Tokunaga O, Tomita K, Nagasawa K, Funaki T, Furuichi M, Miyata I, Yaginuma M, Yamaguchi Y, Yamamoto S, Uehara S, Kurosaki T, Okada K, Ouchi K. Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022. The Pediatric infectious disease journal. 2023;42(10):e369-e76.

2022年

  1. Takahashi YK, Funaki T, Ishiguro A, Miyairi I. Urinary tract infection caused by bacterial pathogens of the respiratory tract in children. Pediatrics international : official journal of the Japan Pediatric Society. 2022;64(1):e15419.
  2. Shoji K, Tsuzuki S, Akiyama T, Matsunaga N, Asai Y, Suzuki S, Iwamoto N, Funaki T, Yamada M, Ozawa N, Yamaguchi K, Miyairi I, Ohmagari N. Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19) in Pregnant Women: A Propensity Score-Matched Analysis of Data From the COVID-19 Registry Japan. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2022;75(1):e397-e402.
  3. Shoji K, Saito J, Nakamura H, Matsumoto K, Oda K, Takesue Y, Miyairi I. Current Aspects of Pediatric Pharmacokinetics and Pharmacodynamics of Antimicrobials in Japan: Importance of the Promotion of Population PK/PD Analysis. The Pediatric infectious disease journal. 2022;41(10):e418-e23.
  4. Shibata M, Matsubara K, Matsunami K, Miyairi I, Kasai M, Kai M, Katayama Y, Maruyama T, Le Doare K. Epidemiology of group B streptococcal disease in infants younger than 1 year in Japan: a nationwide surveillance study 2016-2020. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2022;41(4):559-71.
  5. Okubo Y, Nishi A, Michels KB, Nariai H, Kim-Farley RJ, Arah OA, Uda K, Kinoshita N, Miyairi I. The consequence of financial incentives for not prescribing antibiotics: a Japan's nationwide quasi-experiment. International journal of epidemiology. 2022;51(5):1645-55.
  6. Okada K, Horikoshi Y, Nishimura N, Ishii S, Nogami H, Motomura C, Miyairi I, Tsumura N, Mori T, Ito K, Honma S, Nagai K, Tanaka H, Hayakawa T, Abe C, Ouchi K. Clinical evaluation of a new rapid immunochromatographic test for detection of Bordetella pertussis antigen. Scientific reports. 2022;12(1):8069.
  7. Ogawa E, Shoji K, Uehara Y, Miyairi I. Retropharyngeal Abscess Caused by Community-Acquired MRSA USA300 Clone in a 1-Year-Old Japanese Girl. Japanese journal of infectious diseases. 2022;75(4):403-6.
  8. Myojin S, Pak K, Sako M, Kobayashi T, Takahashi T, Sunagawa T, Tsuboi N, Ishikura K, Kubota M, Kubota M, Igarashi T, Morioka I, Miyairi I. Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study. PloS one. 2022;17(2):e0263349.
  9. Katsuta T, Shimizu N, Okada K, Tanaka-Taya K, Nakano T, Kamiya H, Amo K, Ishiwada N, Iwata S, Oshiro M, Okabe N, Kira R, Korematsu S, Suga S, Tsugawa T, Nishimura N, Hishiki H, Fujioka M, Hosoya M, Mizuno Y, Mine M, Miyairi I, Miyazaki C, Morioka I, Morishima T, Yoshikawa T, Wada T, Azuma H, Kusuhara K, Ouchi K, Saitoh A, Moriuchi H. The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan. Pediatrics international : official journal of the Japan Pediatric Society. 2022;64(1):e14912.
  10. Iwamoto N, Morisaki N, Uda K, Kasai M, Kodama EN, Ohmagari N, Miyairi I. Change in use of pediatric oral antibiotics in Japan, pre- and post-implementation of an antimicrobial resistance action plan. Pediatrics international : official journal of the Japan Pediatric Society. 2022;64(1):e15197.
  11. Isobe Y, Chang B, Endoh A, Miyairi I. Recurrent group B streptococcus bacteremia despite discontinuing contaminated breast milk. Pediatrics international : official journal of the Japan Pediatric Society. 2022;64(1):e15274.
  12. Inoue K, Kobayashi S, Sato K, Kanno H, Kantou R, Naganuma Y, Kawamura N, Oike Y, Kobayashi M, Yanai M, Suzuki A, Kurai H, Miyairi I, Kutsuna S, Gu Y. Regional Antimicrobial Stewardship Program in a Provincial Medical Zone in Japan: a Multifaceted Approach. Japanese journal of infectious diseases. 2022;75(4):347-54.
  13. Hashimoto R, Shoji K, Ishiguro A, Miyairi I. Clinical characteristics of bacteremic urinary tract infection due to third-generation cephalosporin-resistant Escherichia coli in children. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2022;28(3):469-71.
  14. Fukayama H, Shoji K, Yoshida M, Iijima H, Maekawa T, Ishiguro A, Miyairi I. Bacterial meningitis due to the Streptococcus mitis group in children with cerebrospinal fluid leak. IDCases. 2022;27:e01406.

2021年

  1. Shoji K, Saito J, Nakagawa H, Funaki T, Fukuda A, Sakamoto S, Kasahara M,　Momper JD, Capparelli EV, Miyairi I. Population Pharmacokinetics and Dosing　Optimization of Vancomycin in Pediatric Liver Transplant Recipients. Microbiol　Spectr. 2021 Oct 31;9(2):e0046021.
  2. Saito-Abe M, Yamamoto-Hanada K, Shoji K, Sato M, Irahara M, Taniguchi Y,　Sekiyama M, Mise N, Ikegami A, Shimono M, Suga R, Sanefuji M, Ohga S, Oda M,　Mitsubuchi H, Miyairi I, Ohya Y. Measles antibody seropositivity among children　with allergic diseases: A cross-sectional study in the Japan Environment &　Children's Pilot Study. PLoS One. 2021 Sep 22;16(9):e0257721. 
  3. Takahashi Y, Matsui T, Maekawa T, Ishiguro A, Miyairi I. Periungual　desquamation in a child with Yersinia pseudotuberculosis infection. Pediatr Int.　2021 Sep;63(9):1144-1145.
  4. Okubo Y, Nariai H, Michels KB, Kim-Farley RJ, Nishi A, Arah OA, Kinoshita N,　Uda K, Miyairi I. Change in clinical practice variations for antibiotic　prescriptions across different pediatric clinics: A Japan's nationwide　observational study. J Infect Chemother. 2021 Nov;27(11):1621-1625. 
  5. Shimizu S, Sakamoto S, Yamada M, Fukuda A, Yanagi Y, Uchida H, Mimori K,　Shoji K, Funaki T, Miyairi I, Nakano N, Haga C, Yoshioka T, Imadome KI, Horikawa　R, Kasahara M. Immunological features and complications in patients with　glycogen storage disease 1b after living donor liver transplantation. Pediatr　Transplant. 2021 Dec;25(8):e14104.
  6. Katsuta T, Shimizu N, Okada K, Tanaka-Taya K, Nakano T, Kamiya H, Amo K,　Ishiwada N, Iwata S, Oshiro M, Okabe N, Kira R, Korematsu S, Suga S, Tsugawa T,　Nishimura N, Hishiki H, Fujioka M, Hosoya M, Mizuno Y, Mine M, Miyairi I,　Miyazaki C, Morioka I, Morishima T, Yoshikawa T, Wada T, Azuma H, Kusuhara K,　Ouchi K, Saitoh A, Moriuchi H. The clinical characteristics of pediatric　coronavirus disease 2019 in 2020 in Japan. Pediatr Int. 2021 Jul　7:10.1111/ped.14912.
  7. Aiba H, Shoji K, Shinjo D, Ishiguro A, Miyairi I. Third-generation　cephalosporin-resistant pneumococcal meningitis in children. Pediatr Int. 2021　Sep;63(9):1133-1135. 
  8. Yoshida M, Funata K, Koinuma G, Miyairi I. Plastic Bronchitis Associated with　Influenza. J Pediatr. 2021 Nov;238:336-337.
  9. Yoshida M, Miyahara Y, Orimo K, Kono N, Narita M, Ohya Y, Matsumoto K,　Nakagawa S, Ueki S, Morita H, Miyairi I. Eosinophil Extracellular Traps in the　Casts of Plastic Bronchitis Associated With Influenza Virus Infection. Chest.　2021 Sep;160(3):854-857.
  10. Lee K, Iguchi A, Uda K, Matsumura S, Miyairi I, Ishikura K, Ohnishi M, Seto　J, Ishikawa K, Konishi N, Obata H, Furukawa I, Nagaoka H, Morinushi H, Hama N,　Nomoto R, Nakajima H, Kariya H, Hamasaki M, Iyoda S. Whole-Genome Sequencing of　Shiga Toxin-Producing Escherichia coli OX18 from a Fatal Hemolytic Uremic　Syndrome Case. Emerg Infect Dis. 2021 May;27(5):1509-1512.
  11. Yamada M, Funaki T, Shoji K, Miyairi I, Fukuda A, Sakamoto S, Imadome KI,　Kasahara M. Do Not Delay: Safe Operation for Pediatric Living-donor Liver　Transplantation Programs in the COVID-19 Era. Transplantation. 2021 Mar　1;105(3):e39-e40. 
  12. Kamei K, Miyairi I, Shoji K, Arai K, Kawai T, Ogura M, Ishikura K, Sako M,　Nakamura H. Live attenuated vaccines under immunosuppressive agents or　biological agents: survey and clinical data from Japan. Eur J Pediatr. 2021　Jun;180(6):1847-1854. 
  13. Minato S, Yoshida M, Shoji K, Yotani N, Takeshita K, Takeuchi N, Ishiwada N,　Kubota M, Ishiguro A, Miyairi I. A Case Report of Bacterial Meningitis Caused by　an Emerging Strain of Penicillin-Resistant Non-Vaccine Serotype 10A. Jpn J　Infect Dis. 2021 Sep 22;74(5):477-480.
  14. Hamasuna R, Yasuda M, Takahashi S, Uehara S, Kawai Y, Miyairi I, Arakawa S,　Kiyota H; Japanese Association for Infectious Disease/Japanese Society of　Chemotherapy, The JAID/JSC Guide/Guidelines to Clinical Management of Infectious　Disease Preparing Committee, Sexually Transmitted Infection Working Group. The　JAID/JSC guidelines to Clinical Management of Infectious Disease 2017 concerning　male urethritis and related disorders. J Infect Chemother. 2021　Apr;27(4):546-554.
  15. Saito J, Shoji K, Oho Y, Kato H, Matsumoto S, Aoki S, Nakamura H, Ogawa T,　Hasegawa M, Yamatani A, Miyairi I. Reply to Béranger et al., "Integration of　Continuous Renal Replacement Therapy in a Meropenem Population Pharmacokinetics　Model in Critically Ill Children". Antimicrob Agents Chemother. 2021 Mar　18;65(4):e02592-20.
  16. Morioka S, Gu Y, Tsuzuki S, Fujitomo Y, Soeda H, Nakahama C, Hasegawa N,　Maesaki S, Maeda M, Matsumoto T, Miyairi I, Ohmagari N. Determinants of clinic　doctors' attitudes concerning antimicrobial prescription for patients with　common colds or bronchitis: Additional analysis of a nationwide survey conducted　by the Japanese Society of Chemotherapy and the Japanese Association for　Infectious Diseases. J Infect Chemother. 2021 Feb;27(2):131-138.
  17. Funaki T, Shoji K, Fukuda A, Sakamoto S, Kasahara M, Miyairi I. Safety of LAVs administered after pediatric LT. Pediatr Transplant. 2021 Aug;25(5):e13937.
  18. Iwata S, Takata M, Morozumi M, Miyairi I, Matsubara K, Ubukata K; Pneumococcal Meningitis Surveillance Study Group. Drastic reduction in pneumococcal meningitis in children owing to the introduction of pneumococcal conjugate vaccines: Longitudinal analysis from 2002 to 2016 in Japan. J Infect Chemother. 2021 Apr;27(4):604-612.
  19. Saito J, Shoji K, Oho Y, Kato H, Matsumoto S, Aoki S, Nakamura H, Ogawa T, Hasegawa M, Yamatani A, Miyairi I. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Pediatric Patients. Antimicrob Agents Chemother. 2021 Jan 20;65(2):e01909-20.
  20. Shoji K, Koyama-Wakai C, Uda K, Fukuda A, Sakamoto S, Kasahara M, Miyairi I. WU polyomavirus detection in a pediatric liver transplant recipient with interstitial pneumonitis. J Infect Chemother. 2021 Mar;27(3):530-532.
  21. Ubukata K, Wajima T, Takata M, Murayama SY, Morozumi M, Mukae H, Ishida T, Miyairi I, Kiyota H, Iwata S. Molecular epidemiological characterization in mucoid-type Streptococcus pneumoniae isolates obtained from invasive pneumococcal disease patients in Japan. J Infect Chemother. 2021 Feb;27(2):211-217.